Immunization against human papillomavirus type 16 tumor cells with recombinant vaccinia viruses expressing E6 and E7
- 1 March 1991
- Vol. 181 (1) , 62-69
- https://doi.org/10.1016/0042-6822(91)90470-v
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Vaccination against polyoma virus (PYV) tumors using vaccinia-PYV recombinants: A major tumor-specific transplantation antigen (TSTA) epitope resides within the C-terminal segment of middle-T proteinInternational Journal of Cancer, 1990
- Studies on the Polyoma Virus Tumor-Specific Transplantation Antigen (Tsta)Advances in Cancer Research, 1990
- Recombinant polyoma—vaccinia viruses: T antigen expression vectors and anti-tumor immunization agentsBiochimie, 1988
- DNA sequence of the HPV-16 E5 ORF and the structural conservation of its encoded proteinVirology, 1988
- HUMAN PAPILLOMAVIRUS INFECTIONS IN WOMEN WITH AND WITHOUT ABNORMAL CERVICAL CYTOLOGYPublished by Elsevier ,1987
- Tumour prevention and rejection with recombinant vacciniaNature, 1987
- An analysis of 5'-noncoding sequences from 699 vertebrate messenger RNAsNucleic Acids Research, 1987
- AIDS virus env Protein Expressed from a Recombinant Vaccinia VirusNature Biotechnology, 1986
- Point mutations define a sequence flanking the AUG initiator codon that modulates translation by eukaryotic ribosomesCell, 1986
- Expression of rabies virus glycoprotein from a recombinant vaccinia virusNature, 1984